Fordele og potentielle risici skal derfor vurderes i henhold til de officielle anbefalinger, når vaccinen administreres til gravide kvinder.
Healthcare providers need to assess the benefits and potential risks of administering the vaccine to pregnant women taking into consideration official recommendations.